Related Experiment Videos
A robust method for detecting CHK2/RAD53 mutations in genomic DNA
Nayanta Sodha1, Richard S Houlston, Richard Williams
1Royal Marsden NHS Trust, Surrey, UK. nayanta@icr.ac.uk
Human Mutation
|January 17, 2002
Summary
Screening for CHK2 mutations can be error-prone due to homologous sequences. A new long-range PCR method accurately analyzes the functional CHK2 gene copy for comprehensive mutation detection.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Germline mutations in CHK2 (Checkpoint Kinase 2) are associated with various cancers.
- Standard screening methods for CHK2 mutations, such as heteroduplex CSGE and PCR, can be unreliable.
- Homologous regions in the genome can interfere with accurate mutation detection.
Purpose of the Study:
- To identify the cause of spurious PCR fragments during CHK2 mutation screening.
- To develop a reliable method for comprehensive mutational analysis of the functional CHK2 gene.
Main Methods:
- Heteroduplex CSGE and direct sequencing were used to analyze PCR fragments.
- Public sequence databases were searched for homologous regions to CHK2 exons.
- A novel strategy employing long-range PCR was developed to specifically amplify the functional CHK2 gene.
Main Results:
- Additional PCR fragments were generated from the 3' end of CHK2 (exons 11-14), indicating amplification of homologous loci.
- High homology was found between CHK2 exons 10-14 and other genomic regions.
- The developed long-range PCR method successfully screened the functional CHK2 copy, circumventing amplification errors.
Conclusions:
- Standard PCR-based screening methods for CHK2 mutations are prone to errors due to pseudogene amplification.
- Long-range PCR provides a robust strategy for accurate and comprehensive mutational analysis of the functional CHK2 gene.
- This improved methodology is crucial for reliable genetic screening in cancer diagnostics.